Brink, W. v. d., & Mann, K. (2015). Safety and tolerability of as-needed nalmefene in the treatment of alcohol dependence: Results from the Phase III clinical programme. Expert opinion on drug safety, 14(4), . https://doi.org/10.1517/14740338.2015.1011619
Chicago Style (17th ed.) CitationBrink, Wim van den, and Karl Mann. "Safety and Tolerability of As-needed Nalmefene in the Treatment of Alcohol Dependence: Results from the Phase III Clinical Programme." Expert Opinion on Drug Safety 14, no. 4 (2015). https://doi.org/10.1517/14740338.2015.1011619.
MLA (9th ed.) CitationBrink, Wim van den, and Karl Mann. "Safety and Tolerability of As-needed Nalmefene in the Treatment of Alcohol Dependence: Results from the Phase III Clinical Programme." Expert Opinion on Drug Safety, vol. 14, no. 4, 2015, https://doi.org/10.1517/14740338.2015.1011619.